APP and Alzheimer disease: Another study by Jiang and colleagues on HEK293‐APP695 cells and APP/PS1 mice validated the anti‐AD activity of temsirolimus, which marked a reduction of hippocampal apoptosis and Aβ plaques, as well as improvement in memory and cognition [140].